TNYA · Tenaya Therapeutics, Inc.

Summary

Tenaya Therapeutics, Inc. filed an 8-K on March 11, 2026, including a press release as Exhibit 99.1 under Item 2.02 (Results of Operations) and Item 9.01, which are not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. The filing discloses no specific financial results or operational details in the provided document content.

Key takeaways

• Filing date: 2026-03-11
• Form Type: 8-K
• Item 2.02: Results of Operations
• Item 9.01: Financial Statements and Exhibits
• Exhibit 99.1: Press Release dated March 11, 2026